(Q46885454)

26 December 2017

title

Conceptual basis and methodology of the SOPHIA study (English)

1 reference

26 December 2017

author

Claudio Ferri

19

1 reference

26 December 2017

Gianfranco Parati

25

1 reference

26 December 2017

Fabio Macciardi

29

1 reference

26 December 2017

Benedetta Stancanelli

object named as

B Stancanelli

30

0 references

author name string

N Glorioso

1

1 reference

26 December 2017

G Argiolas

2

1 reference

26 December 2017

F Filigheddu

3

1 reference

26 December 2017

C Troffa

4

1 reference

26 December 2017

F Cocco

5

1 reference

26 December 2017

E Bulla

6

1 reference

26 December 2017

P Bulla

7

1 reference

26 December 2017

R Zaninello

8

1 reference

26 December 2017

S Degortes

9

1 reference

26 December 2017

S Pitzoi

10

1 reference

26 December 2017

F Frau

11

1 reference

26 December 2017

S Fadda

12

1 reference

26 December 2017

P Pinna Parpaglia

13

1 reference

26 December 2017

G Bernini

14

1 reference

26 December 2017

M Bardini

15

1 reference

26 December 2017

F Fallo

16

1 reference

26 December 2017

L Malatino

17

1 reference

26 December 2017

G Regolisti

18

1 reference

26 December 2017

D Cusi

20

1 reference

26 December 2017

A Sciacqua

21

1 reference

26 December 2017

F Perticone

22

1 reference

26 December 2017

E Degli Esposti

23

1 reference

26 December 2017

C Baraccani

24

1 reference

26 December 2017

F Veglio

26

1 reference

26 December 2017

P Mulatero

27

1 reference

26 December 2017

T A Williams

28

1 reference

26 December 2017

Study Group on Cardiovascular Pharmacogenomics of Italian Society of Hypertension

31

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

published in

Pharmacogenomics

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

page(s)

1497-1509

1 reference

26 December 2017

issue

11

1 reference

26 December 2017

Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

How to explain the differences between renin angiotensin system modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Renal function in relation to three candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Inhibition of the renin-angiotensin system and the prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Variants of the CYP11B2 gene predict response to therapy with candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

CYP2C9 genetic variants and losartan oxidation in a Turkish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Ambulatory blood-pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Reproducibility of in vivo carotid intima-media thickness measurements: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Principal components analysis corrects for stratification in genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Genome-wide strategies for detecting multiple loci that influence complex diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Molecular basis of human hypertension: role of angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

ACE and α-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

Genetic polymorphism of the renin???angiotensin???aldosterone system and arterial hypertension in the Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.11.1497

10.2217/14622416.8.11.1497

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

18034615

1 reference

26 December 2017